$RLFTF news https://relieftherapeutics.com/neurorx-and-relief-announce-topline-efficacy-data-from-patients-treated-with-rlf-100-aviptadil-under-the-u-s-fda-expanded-access-protocol-authorization-for-respiratory-failure-related-to/